2013
DOI: 10.1073/pnas.1218573110
|View full text |Cite
|
Sign up to set email alerts
|

Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB 1 receptor blockade

Abstract: Complex interactions between periphery and the brain regulate food intake in mammals. Cannabinoid type-1 (CB 1 ) receptor antagonists are potent hypophagic agents, but the sites where this acute action is exerted and the underlying mechanisms are not fully elucidated. To dissect the mechanisms underlying the hypophagic effect of CB 1 receptor blockade, we combined the acute injection of the CB 1 receptor antagonist rimonabant with the use of conditional CB 1 -knockout mice, as well as with pharmacological modu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
90
2

Year Published

2013
2013
2017
2017

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 107 publications
(94 citation statements)
references
References 64 publications
(88 reference statements)
2
90
2
Order By: Relevance
“…Interestingly, recent data revealed that the anorectic and anxiogenic effects of rimonabant require peripheral activation of sympathetic activity (26). Consistently, the present data indicate that control of adrenergic/noradrenergic transmission by CB1 receptors is involved in the central-peripheral control of behavior.…”
Section: Discussionsupporting
confidence: 89%
“…Interestingly, recent data revealed that the anorectic and anxiogenic effects of rimonabant require peripheral activation of sympathetic activity (26). Consistently, the present data indicate that control of adrenergic/noradrenergic transmission by CB1 receptors is involved in the central-peripheral control of behavior.…”
Section: Discussionsupporting
confidence: 89%
“…Given that the physiological actions of cannabis are mediated by activation of the CB1 receptor, this suggested that a normative function of the eCB system could be to dampen or buffer against the effects of stress. Consistent with this hypothesis, pharmacological or genetic disruption of eCB signaling reliably produces a neurobehavioral phenotype, which directly parallels the classical manifestation of a stress response, including activation of the HPA axis, increased anxiety, suppressed feeding behavior, reduced responsiveness to rewarding stimuli, hypervigilance and arousal, enhanced grooming behavior, and impaired cognitive flexibility (Bellocchio et al, 2013;Friemel et al, 2014;Haller et al, 2004;Marsicano et al, 2002;Patel et al, 2004;Sanchis-Segura et al, 2004;Santucci et al, 1996;Shonesy et al, 2014;Tallett et al, 2007;Varvel and Lichtman, 2002). As such, these data indicate that there is a prominent stressinhibitory role of the eCB system.…”
Section: +supporting
confidence: 55%
“…Additionally, genetic deletion of CB 1 R in the PVN causes phenotypic changes due to increased SNSdriven energy expenditure and BAT thermogenesis (97). Finally, also the rapid hypophagic effect of rimonabant observed within 1-h from its administration relies on β-adrenergic transmission (98).…”
Section: Back To the Brainmentioning
confidence: 99%